- Source type
- Clinical resource
- Access type
- Publisher
- Publisher
- UC Irvine School of Medicine
- Date
- 2026-07-02
- Added
- 2026-07-05
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
82
Professional clinical guidance
- Publisher type
- Professional guidance
- Bias profile
- Moderate
This source is strongest for safety and consumer context and weaker for mechanism and trial discovery.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 63/100
- Context Source
- Clinical outcomes
- 78/100
- Strong Support
- Mechanism
- 63/100
- Context Source
- Safety
- 86/100
- Strong Support
- Consumer context
- 82/100
- Strong Support
- Trial discovery
- 63/100
- Context Source
Best used for
- Clinical context
- Practice guidance
Weak for
- Replacing primary evidence
Used in Viral Vitalism
Doctors Paired an Investigational Antibiotic With Phage Therapy in a Near-Untreatable Infection
Roles: Primary source
Related studies
No structured study record is currently attached to this source.
Related sources
FDA: Neurologic complications after anesthesia linked to genetic variant
Primary FDA alert for rare anesthesia-linked neurologic outcomes in patients of maternal Venezuelan ancestry.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 1 connection
NIH: All of Us is now the largest integrated genomics and health database
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 91
- Publisher
- NIH
- Access
- Official
- Usage
- 1 connection
GEN: Schistosomiasis vaccine shows strong immune memory
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 60
- Publisher
- GEN
- Access
- Publisher
- Usage
- 0 connections
Medical Xpress / Texas Tech University: experimental vaccine for neglected disease
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 60
- Publisher
- Medical Xpress / Texas Tech University
- Access
- Publisher
- Usage
- 0 connections
CHOC: Compassionate-use therapies for a deadly infection save the life of cancer patient
Patient-story verification for UCI/CHOC compassionate-use infection case.
- Trust score
- 82
- Publisher
- Children's Hospital of Orange County
- Access
- Publisher
- Usage
- 1 connection
Nature Communications: SagA inactivation increases vancomycin susceptibility
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 88
- Publisher
- Nature Communications
- Access
- Publisher
- Usage
- 0 connections